Form EFFECT NeuroSense Therapeutics
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 31, 2026 4:00 P.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Global Times: Bishkek time: The SCO once again addresses the question of global governance
- West Physics Announces Acquisition of Radiographic Testing Services, Inc.
- Remittix vs Little Pepe: Comparing PayFi Utility, Presale Progress, Product Delivery and Listing Catalysts
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share